 | Up a level |
2021
Hoeper, Marius M., Al-Hiti, Hikmet, Benza, Raymond L., Chang, Sung-A, Corris, Paul A., Gibbs, J. Simon R., Grunig, Ekkehard, Jansa, Pavel 
ORCID: 0000-0002-3711-7064, Klinger, James R., Langleben, David, McLaughlin, Vallerie V., Meyer, Gisela M. B., Ota-Arakaki, Jaquelina, Peacock, Andrew J., Pulido, Tomas, Rosenkranz, Stephan, Vizza, Carmine Dario ORCID: 0000-0002-3540-4983, Vonk-Noordegraaf, Anton, White, R. James, Chang, Mikyung, Kleinjung, Frank, Meier, Christian, Paraschin, Karen, Ghofrani, Hossein Ardeschir and Simonneau, Gerald
(2021).
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Lancet Resp. Med., 9 (6).
S. 573 - 585.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2213-2600